Riskpilot← Back to searchSign inGet full accessRabe Medtech AB
ABActiveOrg 5563101574Sjöviksvägen 148 Lgh 1904Manufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 19881-4 employees
Revenue 2025
SEK 9K
EBITDA margin
-6688.9%
-2636% vs 2024
Equity ratio
91.0%
Financial strength
Net profit 2025
SEK -112K
-185% vs 2024
| Revenue | SEK 9K | — |
| EBITDA | SEK -602K | -2636% |
| Net profit | SEK -112K | -185% |
| Total assets | SEK 2,4M | +3% |
| Equity | SEK 2,2M | -5% |
| Employees | — | — |
Legal name
Rabe Medtech AB
Org number
5563101574
Legal form
Aktiebolag
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
1 februari 1988
Share capital
SEK 1 000 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Råbe, Nils Gunnar Oscar
Company purpose
Bolaget skall bedriva utveckling och forskning samt försäljning och handel med medicintekniska produkter, system och utrustningar. Bolaget skall även handla med värdepapper samt därmed förenlig verksamhet.
Address
Sjöviksvägen 148 Lgh 1904
Email
gunnar.rabe@radscan.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 26 | 29 | 14 | 5 | 9 | 23 | 0 | 9 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −21 | — | 8 | — | −8 | −26 | −10 | 5 | −22 | −602 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −21 | 0 | 8 | 0 | −8 | −26 | −10 | 5 | −22 | −602 |
| Net financials | −74 | 46 | 43 | 10 | 13 | −673 | −1 068 | −135 | 186 | 454 |
| Profit before tax | −94 | 46 | 51 | 9 | 5 | −356 | −518 | −130 | 164 | −110 |
| Tax | −4 | −8 | −10 | −4 | −1 | −0 | −0 | −0 | −32 | −2 |
| Net profit | −98 | 38 | 41 | 5 | 4 | −356 | −518 | −130 | 132 | −112 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 375 | 3 520 | 3 572 | 3 576 | 3 578 | 3 216 | 2 633 | 2 203 | 2 365 | 2 441 |
| Equity | 4 369 | 3 157 | 3 198 | 3 203 | 3 207 | 2 851 | 2 333 | 2 203 | 2 334 | 2 222 |
| Long-term debt | 0 | 350 | 350 | 364 | 365 | 365 | 300 | 0 | 0 | 205 |
| Short-term debt | 6 | 13 | 24 | 8 | 5 | 0 | 0 | 0 | 31 | 14 |
| Total debt | 6 | 363 | 374 | 372 | 370 | 365 | 300 | — | 31 | 219 |
EBITDA margin
-6688.9%
This company
15.8%
Market median
-42435% vs market
20162025
Equity ratio
91.0%
This company
38.2%
Market median
+138% vs market
20162025
Return on equity
-5.0%
This company
18.4%
Market median
-127% vs market
20162025
Net profit margin
-1244.4%
This company
8.1%
Market median
-15463% vs market
20162025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ME Chief Auditor | Chief Auditor | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Rabe Medtech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Erika Inestam | Chief Auditor | 0 companies |
| Markus Nils Johan Råbe | Deputy Board Member | 0 companies |
| Mattias Erik Oscar Råbe | Deputy Board Member | 0 companies |
| Nils Gunnar Oscar Råbe | Board of Directors | 0 companies |
| Mattias Erik Oscar Råbe | Deputy Board Member | 0 companies |